Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | LTA4H |
| Upstream (Parents) |
|---|
| (<<) ACAT2 → LTA4H |
| (<<) BDH1 → LTA4H |
| (<<) CYP1A2 → LTA4H |
| (<<) DAZAP2 → LTA4H |
| (<<) DNM1L → LTA4H |
| (<<) GALK1 → LTA4H |
| (<<) GRHPR → LTA4H |
| (<<) GSTZ1 → LTA4H |
| (<<) MYC → LTA4H |
| (<<) RBKS → LTA4H |
| (<<) RDH16 → LTA4H |
| (<<) RPL23A → LTA4H |
| Downstream (Children) |
|---|
| LTA4H → BBC3 (>>) |
| LTA4H → CAT (>>) |
| LTA4H → CD3EAP (>>) |
| LTA4H → CDK7 (>>) |
| LTA4H → CEBPA (>>) |
| LTA4H → CRLF3 (>>) |
| LTA4H → CYP1A1 (>>) |
| LTA4H → ENC1 (>>) |
| LTA4H → F2RL1 (>>) |
| LTA4H → FDPS (>>) |
| LTA4H → FZD5 (>>) |
| LTA4H → KPNA1 (>>) |
| LTA4H → KREMEN2 (>>) |
| LTA4H → MAP3K4 (>>) |
| LTA4H → PHLDA1 (>>) |
| LTA4H → SEPW1 (>>) |
| LTA4H → SMAD2 (>>) |
| LTA4H → SPR (>>) |
| LTA4H → VPS28 (>>) |
| LTA4H → VTCN1 (>>) |
